{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:44:55Z","timestamp":1790304295714,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04286-9","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:53:34Z","timestamp":1751086414000},"page":"17-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Circulating miRNAs in Graves\u2019 ophthalmopathy: a systematic review"],"prefix":"10.1007","volume":"90","author":[{"given":"Evangelia","family":"Syrakouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Geropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Laskou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissavet","family":"Anestiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyro","family":"Syrakouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Koimtzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Geropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Giannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Sapalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriakos","family":"Psarras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"4286_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr030","volume":"99","author":"MPJ Vanderpump","year":"2011","unstructured":"M.P.J. Vanderpump, The epidemiology of thyroid disease. Br. Med. Bull. 99, 39\u201351 (2011).","journal-title":"Br. Med. Bull."},{"issue":"16","key":"4286_CR2","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"T.J. Smith, L. Heged\u00fcs, Graves\u2019 disease. N. Engl. J. Med. 375(16), 1552\u20131565 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"4286_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281\u2013297 (2004).","journal-title":"Cell"},{"key":"4286_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/EJE-22-0247","volume":"187","author":"HO Ueland","year":"2022","unstructured":"H.O. Ueland, G.\u00c5 Ueland, K. L\u00f8v\u00e5s, L.E. Breivk, A.S. Thrane, A.M. Stokland et al., Novel inflammatory biomarkers in thyroid eye disease. Eur. J. Endocrinol. 187, 293\u2013300 (2022).","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"4286_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-18-0039","volume":"178","author":"W Wiersinga","year":"2018","unstructured":"W. Wiersinga, M. \u017darkovi\u0107, L. Bartalena, S. Donati, P. Perros, O. Okosieme et al., Predictive score for the development or progression of Graves\u2019 orbitopathy in patients with newly diagnosed Graves\u2019 hyperthyroidism. Eur. J. Endocrinol. 178(6), 635\u2013643 (2018).","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"4286_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S0002-9440(10)63488-8","volume":"163","author":"L Koumas","year":"2003","unstructured":"L. Koumas, T.J. Smith, S. Feldon, N. Blumberg, R.P. Phipps, Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am. J. Pathol. 163(4), 1291\u20131300 (2003).","journal-title":"Am. J. Pathol."},{"issue":"10","key":"4286_CR7","doi-asserted-by":"publisher","first-page":"e26261","DOI":"10.1371\/journal.pone.0026261","volume":"6","author":"JS Yoon","year":"2011","unstructured":"J.S. Yoon, H.J. Lee, S.H. Choi, E.-J. Chang, S.Y. Lee, E.J. Lee, Quercetin inhibits IL-1\u03b2-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves\u2019 orbitopathy. PLoS One 6(10), e26261 (2011).","journal-title":"PLoS One"},{"issue":"6","key":"4286_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s40291-016-0221-4","volume":"20","author":"C Backes","year":"2016","unstructured":"C. Backes, E. Meese, A. Keller, Specific miRNA disease biomarkers in blood, serum and plasma: challenges and prospects. Mol. Diagn. Ther. 20(6), 509\u2013518 (2016).","journal-title":"Mol. Diagn. Ther."},{"issue":"13","key":"4286_CR9","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1167\/iovs.19-27865","volume":"60","author":"CF Woeller","year":"2019","unstructured":"C.F. Woeller, E. Roztocil, C. Hammond, S.E. Feldon, TSHR signaling stimulates proliferation through PI3K\/Akt and induction of miR-146a and miR-155 in thyroid eye disease orbital fibroblasts. Invest. Ophthalmol. Vis. Sci. 60(13), 4336\u20134345 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"4286_CR10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1507\/endocrj.EJ14-0246","volume":"61","author":"H Wei","year":"2014","unstructured":"H. Wei, M. Guan, Y. Qin, C. Xie, X. Fu, F. Gao et al., Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves\u2019 ophthalmopathy. Endocr. J. 61(11), 1087\u20131092 (2014).","journal-title":"Endocr. J."},{"issue":"9","key":"4286_CR11","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.4049\/jimmunol.0900124","volume":"182","author":"U Maitra","year":"2009","unstructured":"U. Maitra, S. Davis, C.M. Reilly, L. Li, Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1. J. Immunol. 182(9), 5763\u20135769 (2009).","journal-title":"J. Immunol."},{"issue":"6","key":"4286_CR12","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1084\/jem.20101823","volume":"208","author":"MP Boldin","year":"2011","unstructured":"M.P. Boldin, K.D. Taganov, D.S. Rao, L. Yang, J.L. Zhao, M. Kalwani et al., miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208(6), 1189\u20131201 (2011).","journal-title":"J. Exp. Med."},{"issue":"50","key":"4286_CR13","doi-asserted-by":"publisher","first-page":"34590","DOI":"10.1074\/jbc.M109.056317","volume":"284","author":"MA Nahid","year":"2009","unstructured":"M.A. Nahid, K.M. Pauley, M. Satoh, E.K.L. Chan, miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J. Biol. Chem. 284(50), 34590\u201334599 (2009).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"4286_CR14","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1210\/jc.2017-02318","volume":"103","author":"R Mart\u00ednez-Hern\u00e1ndez","year":"2018","unstructured":"R. Mart\u00ednez-Hern\u00e1ndez, M. Sampedro-N\u00fa\u00f1ez, A. Serrano-Somavilla, A.M. Ramos-Lev\u00ed, H. de la Fuente, J.C. Trivi\u00f1o et al., A MicroRNA signature for evaluation of risk and severity of autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 103(3), 1139\u20131150 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4286_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jmcb\/mjr007","volume":"3","author":"X Ma","year":"2011","unstructured":"X. Ma, L.E. Becker Buscaglia, J.R. Barker, Y. Li, MicroRNAs in NF-kappaB signaling. J. Mol. Cell Biol. 3(3), 159\u2013166 (2011).","journal-title":"J. Mol. Cell Biol."},{"issue":"15","key":"4286_CR16","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.7150\/ijbs.103977","volume":"20","author":"H Zhang","year":"2024","unstructured":"H. Zhang, Y. Zhou, B. Yu, Y. Deng, Y. Wang, S. Fang et al., Multi-Omics approaches to discover biomarkers of thyroid eye disease: a systematic review. Int. J. Biol. Sci. 20(15), 6038\u20136055 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"4286_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2018.11.004","volume":"106","author":"CM Longo","year":"2019","unstructured":"C.M. Longo, P.J. Higgins, Molecular biomarkers of Graves\u2019 ophthalmopathy. Exp. Mol. Pathol. 106, 1\u20136 (2019).","journal-title":"Exp. Mol. Pathol."},{"issue":"50","key":"4286_CR18","doi-asserted-by":"publisher","first-page":"52361","DOI":"10.1074\/jbc.C400438200","volume":"279","author":"C Esau","year":"2004","unstructured":"C. Esau, X. Kang, E. Peralta, E. Hanson, E.G. Marcusson, L.V. Ravichandran et al., MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 279(50), 52361\u201352365 (2004).","journal-title":"J. Biol. Chem."},{"key":"4286_CR19","doi-asserted-by":"crossref","unstructured":"R.A. Al-Heety, H.S. Al-Hadithi, Circulating miRNA-21-5p role in the development of orbitopathy in Graves disease. Gene Rep. 20, 100793 (2020). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2452014420302077.","DOI":"10.1016\/j.genrep.2020.100793"},{"issue":"1","key":"4286_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/ijms23010153","volume":"23","author":"J Craps","year":"2021","unstructured":"J. Craps, V. Joris, L. Baldeschi, C. Daumerie, A. Camboni, A. Buemi et al., miR-199a downregulation as a driver of the NOX4\/HIF-1\u03b1\/VEGF-A pathway in thyroid and orbital adipose tissues from Graves\u2019 patients. Int. J. Mol. Sci. 23(1), 153 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"4286_CR21","doi-asserted-by":"publisher","first-page":"e0221077","DOI":"10.1371\/journal.pone.0221077","volume":"14","author":"SY Jang","year":"2019","unstructured":"S.Y. Jang, M.K. Chae, J.H. Lee, E.J. Lee, J.S. Yoon, MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves\u2019 orbitopathy. PLoS One 14(8), e0221077 (2019). https:\/\/doi.org\/10.1371\/journal.pone.0221077.","journal-title":"PLoS One"},{"issue":"3","key":"4286_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s41375-020-0947-1","volume":"35","author":"M Rossi","year":"2021","unstructured":"M. Rossi, E. Altomare, C. Botta, M.E. Gallo Cantafio, S. Sarvide, D. Caracciolo et al., miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma. Leukemia 35(3), 823\u2013834 (2021).","journal-title":"Leukemia"},{"issue":"2","key":"4286_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12020-014-0487-4","volume":"49","author":"L Shen","year":"2015","unstructured":"L. Shen, F. Huang, L. Ye, W. Zhu, X. Zhang, S. Wang et al., Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves\u2019 ophthalmopathy. Endocrine 49(2), 445\u2013456 (2015).","journal-title":"Endocrine"},{"issue":"1","key":"4286_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26700-1","volume":"8","author":"L Zhang","year":"2018","unstructured":"L. Zhang, G. Masetti, G. Colucci, M. Salvi, D. Covelli, A. Eckstein et al., Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves\u2019 disease and orbitopathy. Sci. Rep. 8(1), 8386 (2018). https:\/\/doi.org\/10.1038\/s41598-018-26700-1.","journal-title":"Sci. Rep."},{"key":"4286_CR25","doi-asserted-by":"publisher","first-page":"819680","DOI":"10.3389\/fimmu.2022.819680","volume":"13","author":"J Sun","year":"2022","unstructured":"J. Sun, J. Wei, Y. Zhang, J. Li, J. Li, J. Yan et al., Plasma exosomes transfer miR-885-3p targeting the AKT\/NF\u03baB signaling pathway to improve the sensitivity of intravenous glucocorticoid therapy against Graves ophthalmopathy. Front. Immunol. 13, 819680 (2022).","journal-title":"Front. Immunol."},{"issue":"8","key":"4286_CR26","first-page":"1803","volume":"21","author":"Z-J Hu","year":"2017","unstructured":"Z.-J. Hu, J.-F. He, K.-J. Li, J. Chen, X.-R. Xie, Decreased microRNA-146a in CD4+T cells promote ocular inflammation in thyroid-associated ophthalmopathy by targeting NUMB. Eur. Rev. Med. Pharmacol. Sci. 21(8), 1803\u20131809 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"4286_CR27","first-page":"1801","volume":"9","author":"W-J Yang","year":"2017","unstructured":"W.-J. Yang, P.-F. Ma, S.-P. Li, H. Su, Y.-J. Liu, MicroRNA-146a contributes to CD4(+) T lymphocyte differentiation in patients with thyroid ophthalmopathy. Am. J. Transl. Res. 9(4), 1801\u20131809 (2017).","journal-title":"Am. J. Transl. Res."},{"key":"4286_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jaut.2018.08.010","volume":"96","author":"J Thiel","year":"2019","unstructured":"J. Thiel, C. Alter, S. Luppus, A. Eckstein, S. Tan, D. F\u00fchrer et al., MicroRNA-183 and microRNA-96 are associated with autoimmune responses by regulating T cell activation. J. Autoimmun. 96, 94\u2013103 (2019).","journal-title":"J. Autoimmun."},{"key":"4286_CR29","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. G\u00f8tzsche, J.P.A. Ioannidis et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700 (2009).","journal-title":"BMJ"},{"issue":"4","key":"4286_CR30","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"T.X. Lu, M.E. Rothenberg, MicroRNA. J. Allergy Clin. Immunol. 141(4), 1202\u20131207 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"4286_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/embor.2008.224","volume":"10","author":"B Huang","year":"2009","unstructured":"B. Huang, J. Zhao, Z. Lei, S. Shen, D. Li, G.-X. Shen et al., miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep. 10(2), 180\u2013185 (2009).","journal-title":"EMBO Rep."},{"issue":"2","key":"4286_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbrc.2009.09.098","volume":"390","author":"M Karbiener","year":"2009","unstructured":"M. Karbiener, C. Fischer, S. Nowitsch, P. Opriessnig, C. Papak, G. Ailhaud et al., microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem. Biophys. Res. Commun. 390(2), 247\u2013251 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"4286_CR33","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1111\/j.1742-4658.2009.06967.x","volume":"276","author":"Q Lin","year":"2009","unstructured":"Q. Lin, Z. Gao, R.M. Alarcon, J. Ye, Z. Yun, A role of miR-27 in the regulation of adipogenesis. FEBS J. 276(8), 2348\u20132358 (2009). https:\/\/doi.org\/10.1111\/j.1742-4658.2009.06967.x.","journal-title":"FEBS J."},{"issue":"5","key":"4286_CR34","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2337\/db08-1299","volume":"58","author":"H Xie","year":"2009","unstructured":"H. Xie, B. Lim, H.F. Lodish, MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58(5), 1050\u20131057 (2009).","journal-title":"Diabetes"},{"key":"4286_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1677\/JOE-09-0099","volume":"202","author":"L Zhang","year":"2009","unstructured":"L. Zhang, C. Paddon, M.D. Lewis, F. Grennan-jones, M. Ludgate, Gs a signalling suppresses PPAR g 2 generation and inhibits 3T3L1 adipogenesis. J. Endocrinol. 202, 207\u2013215 (2009).","journal-title":"J. Endocrinol."},{"issue":"1","key":"4286_CR36","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jcb.26205","volume":"119","author":"F Tavasolian","year":"2018","unstructured":"F. Tavasolian, E. Abdollahi, R. Rezaei, A.A. Momtazi-Borojeni, Y. Henrotin, A. Sahebkar, Altered expression of MicroRNAs in rheumatoid arthritis. J. Cell Biochem. 119(1), 478\u2013487 (2018).","journal-title":"J. Cell Biochem."},{"issue":"12","key":"4286_CR37","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.4049\/jimmunol.1202993","volume":"190","author":"Q Zhou","year":"2013","unstructured":"Q. Zhou, S. Haupt, I. Prots, K. Th\u00fcmmler, E. Kremmer, P.E. Lipsky et al., miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant. J. Immunol. 190(12), 6579\u20136588 (2013).","journal-title":"J. Immunol."},{"issue":"10","key":"4286_CR38","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00018-016-2167-4","volume":"73","author":"LP Garo","year":"2016","unstructured":"L.P. Garo, G. Murugaiyan, Contribution of MicroRNAs to autoimmune diseases. Cell Mol. Life Sci. 73(10), 2041\u20132051 (2016).","journal-title":"Cell Mol. Life Sci."},{"issue":"15","key":"4286_CR39","doi-asserted-by":"publisher","first-page":"8578","DOI":"10.3390\/ijms23158578","volume":"23","author":"A Lamana","year":"2022","unstructured":"A. Lamana, D. Castro-V\u00e1zquez, H. de la Fuente, A. Triguero-Mart\u00ednez, R. Mart\u00ednez-Hern\u00e1ndez, M. Revenga et al., VIP\/VPAC axis expression in immune-mediated inflammatory disorders: associated miRNA signatures. Int. J. Mol. Sci. 23(15), 8578 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"4286_CR40","doi-asserted-by":"crossref","unstructured":"K. Shahraki, V.I. Pak, A. Najafi, K. Shahraki, P.G. Boroumand, R. Sheervalilou, Non-coding RNA-mediatedepigenetic alterations in Grave\u2019s ophthalmopathy: a scoping systematic review. Non-coding RNA Res. 8(3), 426\u2013450 (2023). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2468054023000240 Available from:.","DOI":"10.1016\/j.ncrna.2023.04.001"},{"issue":"4","key":"4286_CR41","doi-asserted-by":"publisher","first-page":"e240122","DOI":"10.1530\/ETJ-24-0122","volume":"13","author":"H Zhang","year":"2024","unstructured":"H. Zhang, S. Wu, S. Hu, X. Fan, X. Song, T. Feng et al., Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease. Eur. Thyroid. J. 13(4), e240122 (2024).","journal-title":"Eur. Thyroid. J."},{"key":"4286_CR42","doi-asserted-by":"crossref","unstructured":"H. Zhang, J. Fan, J. Qu, Q. Han, H. Zhou, X. Song Predictive markers for anti- in fl ammatory treatment response in thyroid eye disease. 1-11 (2023).","DOI":"10.3389\/fendo.2023.1292519"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04286-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:43Z","timestamp":1758772843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04286-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4286"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04286-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is a systematic review. No ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}